French health authority advises against Moderna COVID-19 vaccine for under 30s

French health authority advises against Moderna COVID-19 vaccine for under 30s France's public health authority has recommended people under 30 be given Pfizer's Comirnaty COVID-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems. Reuters Reuters

PARIS, Nov 9 (Reuters) - France's public health authority has recommended people under 30 be given Pfizer's (PFE.N) Comirnaty COVID-19 vaccine when available instead of Moderna Inc's (MRNA.O) Spikevax jab, which carried comparatively higher risks of heart-related problems.

The Haute Autorite de Sante (HAS), which does not have legal power to ban or licence drugs but acts as an advisor to the French health sector, cited "very rare" risks linked to Myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday.

"Within the population aged under 30, this risk appears to be around five times lesser with Pfizer's Comirnaty jab compared to Moderna's Spikevax jab," HAS said in its opinion published on Monday. ...